These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1242089)

  • 1. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology].
    Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B
    Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
    Bruni KB; Neirotti R; Albonico G; Gamba S; Regis G; D'Adda A; Soldano E; Bruni B
    Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of diabetic microangiopathy. Fluoroangioretinal observations during monocomponent insulin therapy].
    Anselmetti G; Antoniotti V; Barbero PL; Castellazzi R; Gamba S; Bruni B
    Ann Osp Maria Vittoria Torino; 1978; 21(1-6):47-68. PubMed ID: 756200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with monocomponent semi-lente insulin in diabetes of difficult compensation].
    Barbero L; Gamba S; Zanno C; Regis G; Bruni B
    Minerva Med; 1978 Apr; 69(21):1437-42. PubMed ID: 683547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
    Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
    Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor antibodies in diabetes mellitus.
    Batarseh H; Thompson RA; Odugbesan O; Barnett AH
    Clin Exp Immunol; 1988 Jan; 71(1):85-90. PubMed ID: 3280181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic response to mono-component insulin in newly diagnosed diabetic patients.
    Devlin JG; Parameswaran V
    Ir Med J; 1975 Jun; 68(12):301-5. PubMed ID: 1140940
    [No Abstract]   [Full Text] [Related]  

  • 14. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin antibody production studied quantitatively with a modified radioimmunoassay technique and with radioimmunoelectrophoresis in patients treated with monocomponent (MC) insulin.
    Bruni B; Ricci C; Giolitti A; Osenda M; D'Alberto M; Turco GL
    J Nucl Biol Med; 1973; 17(3):123. PubMed ID: 4746315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Factors affecting the antigenicity of exogenous insulin in diabetics].
    Penchev II; Taneva T; Ditsov S; Andreev D
    Vutr Boles; 1985; 24(1):113-9. PubMed ID: 3895740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenicity of insulin preparations.
    Chance RE; Root MA; Galloway JA
    Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late complications of diabetes mellitus-consequence of immunologic reactions?].
    Bemm H; Lohmann D
    Allerg Immunol (Leipz); 1974-1975; 20-21(1):15-20. PubMed ID: 4282823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.
    Czyzyk A; Rogala H; Lawecki J
    Acta Diabetol Lat; 1989; 26(1):17-26. PubMed ID: 2665407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human anti-insulin antibodies.
    Faulk WP; Karam JH; Fudenberg HH
    J Immunol; 1971 Apr; 106(4):1112-6. PubMed ID: 5102837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.